Pacira BioSciences appoints former J&J exec as president

By Emily Bader
Parsippany | Jun 20, 2019 at 1:15 am

Pacira BioSciences Inc., a provider of non-opioid pain management and regenerative health solutions, has appointed Max Reinhardt, a former Johnson & Johnson executive, as its new president.

In this role, Reinhardt will be responsible for overseeing all commercial and medical affairs functions at the Parsippany-based company.

Reinhardt will report to Dave Stack, chairman and CEO. Stack will maintain leadership of Pacira’s commercial and corporate strategy.

Reinhardt, who has more than 20 years of experience in the medical device industry, most recently served as vice president of marketing for DePuy Synthes, part of Johnson & Johnson Medical Devices Companies, where he was in charge of $5.5 billion in revenue from its portfolio of medical solutions. He also led the DePuy Synthes alliance, which included managing its partnership with Pacira. Before that, he was the director of sales and marketing for DePuy Spine and vice president of U.S. sales for DePuy Spine.

“We are delighted to officially welcome Max to the Pacira team. Having worked closely with him throughout our partnership with Johnson & Johnson, I am confident that Max’s vast experience successfully commercializing products across a variety of surgical specialties will be of great benefit to Pacira” Stack said.

 

Emily Bader | ebader@roi-nj.com | emilybader